Research identifies a gene that may be linked to focal cortical dysplasia, a common cause of drug-resistant epilepsy. New research has identified changes (mutations) in a gene called FOXJ3 that may be ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Researchers have discovered that mutations in the FOXJ3 gene act as a "master switch" failure, disrupting how the brain ...
Drug-resistant epilepsy affects millions worldwide, with focal cortical dysplasia (FCD) as one of the leading causes. Yet its ...
The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive ...
Patterson-UTI (PTEN) shares ended the last trading session 6.4% higher at $7.03. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...
Patterson-UTI Energy, Inc. is rated a BUY, offering integrated onshore oil & gas services and trading at a discounted valuation versus peers. PTEN's diversified operations, post-NexTier merger, drive ...
ABSTRACT: Objectives: We aimed to determine the frequency of PTEN (phosphatase with tensin homology deleted in chromosome 10) hypermethylation in renal cell carcinoma (RCC) and its impact on overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results